These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3723485)

  • 41. Oral contraceptives and human cervical mucus lipids.
    Singh EJ
    Am J Obstet Gynecol; 1975 Sep; 123(2):128-32. PubMed ID: 1163575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Oral contraceptives and breast tumors: which pill?].
    La Vecchia C
    Riv Inferm; 1984 Mar; 3(1):54-6. PubMed ID: 6431597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The phasic approach to oral contraception: the triphasic concept and its clinical application.
    Upton GV
    Int J Fertil; 1983; 28(3):121-40. PubMed ID: 6140231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Oral contraception: disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiologic assessment of the risks of oral contraception.
    Petitti DB
    J Reprod Med; 1986 Sep; 31(9 Suppl):887-91. PubMed ID: 3772908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening of Mesua ferrea (Nagkesar) for estrogenic & progestational activity in human & experimental models.
    Meherji PK; Shetye TA; Munshi SR; Vaidya RA; Antarkar DS; Koppikar S; Devi PK
    Indian J Exp Biol; 1978 Aug; 16(8):932-3. PubMed ID: 711261
    [No Abstract]   [Full Text] [Related]  

  • 47. More about natural family planning.
    Gallagher J
    Aust Fam Physician; 1983 Nov; 12(11):786-92. PubMed ID: 6667188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of quinestrol-chlormadinone acetate on the endometrium, cervix uteri and vaginal epithelium].
    Schrodt U; Göretzlehner G
    Endokrinologie; 1971; 57(2):254-9. PubMed ID: 4100550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Special requirements for toxicity testing of oral compounds administered continuously or cyclically.
    Overbeek GA; Hornstra HW; van Julsingha EB; Mumford JP; Zayed I
    Acta Endocrinol Suppl (Copenh); 1974; 185():387-408. PubMed ID: 4206191
    [No Abstract]   [Full Text] [Related]  

  • 50. [3-phase-usage contraceptives].
    Korkhov VV; Lupanova GE
    Farmakol Toksikol; 1989; 52(5):115-9. PubMed ID: 2689209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversed-phase high-performance liquid chromatography for the determination of steroid hormones in oral contraceptives.
    Bond AM; Heritage ID; Briggs MH
    J Chromatogr; 1984 Dec; 315():313-20. PubMed ID: 6526900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative assay of anti-fertility agents by I.R. spectroscopy.
    Chatten LG; Triggs EJ; Glowach SJ
    J Pharm Belg; 1976; 31(1):63-79. PubMed ID: 1255405
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantitative separation of progestins and estrogens from anovulatory formulations.
    Fernández AA; Noceda VT
    J Pharm Sci; 1969 Jun; 58(6):740-4. PubMed ID: 5799767
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pregnancy and estro-progestational compounds].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1976; 4(3):171-3. PubMed ID: 1261728
    [No Abstract]   [Full Text] [Related]  

  • 55. Influence of oral contraceptive agents on kidney function and protein metabolism.
    Brändle E; Gottwald E; Melzer H; Sieberth HG
    Eur J Clin Pharmacol; 1992; 43(6):643-6. PubMed ID: 1493847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use and misuse of the term potency with respect to oral contraceptives.
    Goldzieher JW
    J Reprod Med; 1986 Jun; 31(6 Suppl):533-9. PubMed ID: 3723485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progestational potency of oral contraceptives.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jan; 47(1):106-12. PubMed ID: 1246375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.